Nos publications
Mise à jour août 2024
Pagination
- Page précédente
- Page 23
- Page suivante
Title | Authors | Year Trier par ordre croissant | Journal | Link to Article | Intended Audience | Purpose |
---|---|---|---|---|---|---|
Transfusion-related Acute Lung Injury in the Perioperative Patient | McVey MJ, Kapur R, Cserti-Gazdewich C, Semple JW, Karkouti K, Kuebler WM | 2019 | Anesthesiology | View Transfusion-related Acute Lung Injury in the Perioperative Patient | Health care providers | Clinical research |
Genomic data in prognostic models-what is lost in translation? The case of deletion 17p and mutant TP53 in chronic lymphocytic leukaemia | Chin-Yee B, Sadikovic B, Chin-Yee I | 2019 | Br J Haematol | View Genomic data in prognostic models-what is lost in translation? The case of deletion 17p and mutant TP53 in chronic lymphocytic leukaemia | Researchers | Clinical research |
Fetal and Neonatal Alloimmune Thrombocytopenia: Patient Information | International Collaboration for Transfusion Medicine Guidelines | 2019 | ICTMG.org website | View Fetal and Neonatal Alloimmune Thrombocytopenia: Patient Information | Other | Other |
The association between influenza vaccination and socioeconomic status in high income countries varies by the measure used: a systematic review | Lucyk K, Simmonds KA, Lorenzetti DL, Drews SJ, Svenson LW, Russell ML | 2019 | BMC Med Red Methodol | View The association between influenza vaccination and socioeconomic status in high income countries varies by the measure used: a systematic review | Researchers | Clinical research |
Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization | McEneny-King A, Chelle P, Foster G, Keepanasseril A, Iorio A, Edginton AN | 2019 | J Pharmacokinet Pharmacodyn | View Development and evaluation of a generic population pharmacokinetic model for standard half-life factor VIII for use in dose individualization | Researchers | Clinical research |
Sex-mismatched red blood cell transfusions and mortality: A systematic review and meta-analysis | Zeller MP, Rochwerg B, Jamula E, Li N, Hillis C, Acker JP, Runciman RJR, Lane SJ, Ahmed N, Arnold DM, Heddle NM | 2019 | Vox Sang | View Sex-mismatched red blood cell transfusions and mortality: A systematic review and meta-analysis | Researchers | Clinical research |
What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections? | Drews SJ, Branche AR, Falsey AR, Lee N | 2019 | J Clin Virol | View What is the role of rapid molecular testing for seniors and other at-risk adults with respiratory syncytial virus infections? | Health care providers | Clinical research |
Concentré de recherche : Un sur un million : un modèle pour gérer les réserves de sang rare | Blake J, Clarke G | 2019 | Blood.ca website | View Concentré de recherche : Un sur un million : un modèle pour gérer les réserves de sang rare | Researchers | Clinical research |
A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia | Ivetic N, Arnold D, Smith J, Huynh A, Kelton J, Nazy I | 2019 | Platelets | View A platelet viability assay (PVA) for the diagnosis of heparin-induced thrombocytopenia | Researchers | Basic research |
Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach | Lieberman L, Greinacher A, Murphy M, Bussel J, Bakchoul T, Corke S, Killie M, Kjeldsen-Kragh J, Bertrand G, Oepkes D, Baker J, Hume H, Massey E, Kaplan C, Arnold D, Baidya S, Ryan G, Savoia H, Landry D, Shehata N | 2019 | Br J Haematol | View Fetal and neonatal alloimmune thrombocytopenia: recommendations for evidence-based practice, an international approach | Health care providers | Benchmarking and standard setting |
Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Jenkins C | 2019 | Blood.ca website | View Circulaire d'information utilisation de composants sanguins humains: Composants plasmatiques | Health care providers | Benchmarking and standard setting |
Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries | Iorio A, Stonebraker JS, Chambost H, Makris M, Coffin D, Herr C, Germini F, for the Data Demographics Committee of the World Federation of Hemophilia | 2019 | Ann Intern Med | View Establishing the Prevalence and Prevalence at Birth of Hemophilia in Males: A Meta-analytic Approach Using National Registries | Researchers | Clinical research |
Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? | Levy JH, Ghadimi K, Faraoni D, van Diepen S, Levy B, Hotchkiss R, Connors JM, Iba T, Warkentin TE | 2019 | J Thromb Haemost | View Ischemic limb necrosis in septic shock: What is the role of high-dose vasopressor therapy? | Researchers | Clinical research |
Système Kell : l’anticorps anti-Kpa | Peng S, Meunier D | 2019 | Blood.ca website | View Système Kell : l’anticorps anti-Kpa | Health care providers | Benchmarking and standard setting |
Trends in IVIG use at a tertiary care Canadian center and impact of provincial use mitigation strategies: 10-year retrospective study with interrupted time series analysis | Murphy MSQ, Tinmouth A, Goldman M, Chasse M, Colas JA, Saidenberg E, Shehata N, Fergusson D, Forster AJ, Wilson K | 2019 | Transfusion | View Trends in IVIG use at a tertiary care Canadian center and impact of provincial use mitigation strategies: 10-year retrospective study with interrupted time series analysis | Researchers | Clinical research |
Syndrome respiratoire aigu post-transfusionnel (TRALI) | Petraszko T | 2019 | Blood.ca website | View Syndrome respiratoire aigu post-transfusionnel (TRALI) | Researchers | Clinical research |
Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia | Vollenberg R, Jouni R, Norris PAA, Burg-Roderfeld M, Cooper N, Rummel MJ, Bein G, Marini I, Bayat B, Burack R, Lazarus AH, Bakchoul T, Sachs UJ | 2019 | Haematologica | View Glycoprotein V is a relevant immune target in patients with immune thrombocytopenia | Researchers | Basic research |
MNS System: Anti-M | Clarke G, Côté J, Lane D | 2019 | Blood.ca website | View MNS System: Anti-M | Health care providers | Benchmarking and standard setting |
ResearchUnit: Fighting inflammation with inflammation | Lazarus A | 2019 | Blood.ca website | View ResearchUnit: Fighting inflammation with inflammation | Researchers | Clinical research |
Treating murine inflammatory diseases with an anti-erythrocyte antibody | Crow AR, Kapur R, Koernig S, Campbell IK, Jen C-C, Mott PJ, Marjoram D, Khan R, Kim M, Brasseit J, Cruz-Leal Y, Amash A, Kahlon S, Yougbare I, Ni H, Zuercher AW, Käsermann F, Semple JW, Lazarus AH | 2019 | Sci Transl Med | View Treating murine inflammatory diseases with an anti-erythrocyte antibody | Researchers | Basic research |
Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence | Fingrut W, Rikhraj K, Allan D | 2018 | Vox Sang | View Targeted recruitment of male donors for allogeneic haematopoietic cell transplantation: A review of the evidence | Blood operators | Clinical research |
Concentré de recherche: Où l'on optimise un test de laboratoire pour déterminer la compatibilité entre donneurs et receveurs | Acker J, Branch D | 2018 | Blood.ca website | View Concentré de recherche: Où l'on optimise un test de laboratoire pour déterminer la compatibilité entre donneurs et receveurs | Other | Other |
Anti-M | Clarke G, Cote J, Lane D | 2018 | Blood.ca website | View Anti-M | Researchers | Basic research |
International validation of harmonized definitions for complications of blood donations | Land KJ, Townsend M, Goldman M, Whitaker BI, Perez GE, Wiersum-Osselton JC | 2018 | Transfusion | View International validation of harmonized definitions for complications of blood donations | Blood operators | New or improved product or process |
Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Wan H, Wang Y, Ai J, Brathwaite S, Ni H, Macdonald RL, Hol EM, Meijers JCM, Vergouwen MDI | 2018 | J Thromb Haemost | View Role of von Willebrand factor and ADAMTS-13 in early brain injury after experimental subarachnoid hemorrhage | Researchers | Basic research |
Erythrocyte saturation with IgG is required for inducing antibody-mediated immune suppression and impacts both erythrocyte clearance and antigen-modulation mechanisms | Cruz-Leal Y, Marjoram D, Lazarus AH | 2018 | J Immunol | View Erythrocyte saturation with IgG is required for inducing antibody-mediated immune suppression and impacts both erythrocyte clearance and antigen-modulation mechanisms | Researchers | Basic research |
Fusion to human serum albumin extends the circulatory half-life and duration of antithrombotic action of the Kunitz protease inhibitor domain of Protease Nexin 2 | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | Cell Physiol Biochem | View Fusion to human serum albumin extends the circulatory half-life and duration of antithrombotic action of the Kunitz protease inhibitor domain of Protease Nexin 2 | Researchers | Basic research |
Modeling rare blood in Canada | Blake JT, Clarke G | 2018 | Transfusion | View Modeling rare blood in Canada | Health care providers | New or improved product or process |
Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | de Souza LR, Scott BM, Bhakta V, Donkor DA, Perruzza DL, Sheffield WP | 2018 | Serpins: Methods and Protocols | View Serpin Phage Display: The Use of a T7 System to Probe Reactive Center Loop Libraries with Different Serine Proteinases | Researchers | Other |
Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Red blood cells, Leukocytes Reduced (LR) | Health care providers | Benchmarking and standard setting |
Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Linkins L, Hu G, Warkentin TE | 2018 | Res Pract Thromb Haemost | View Systematic review of fondaparinux for heparin-induced thrombocytopenia: When there are no randomized controlled trials | Researchers | Clinical research |
A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Sheffield WP, Eltringham-Smith LJ, Bhakta V | 2018 | BMC Biotechnol | View A factor XIa-activatable hirudin-albumin fusion protein reduces thrombosis in mice without promoting blood loss | Researchers | Basic research |
Chloride and other electrolyte concentrations in commonly available 5% albumin products | Lai AT, Zeller MP, Millen T, Kavsak P, Szczeklik W, Elahie A, Alhazzani W, D'Aragon F, Jaeschke R, Lamontagne F, Karachi T, Cook D, Meade M, Rochwerg B | 2018 | Crit Care Med | View Chloride and other electrolyte concentrations in commonly available 5% albumin products | Researchers | Clinical research |
Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Carter RLR, Talbot K, Hur WS, Meixner SC, Van Der Gugten JG, Holmes DT, Côté HCF, Kastrup CJ, Smith TW, Lee AYY, Pryzdial ELG | 2018 | J Thromb Haemost | View Rivaroxaban and Apixaban induce clotting factor Xa fibrinolytic activity | Health care providers | Basic research |
The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Kavsak PA, Ainsworth C, Arnold DM, Scott T, Clark L, Ivica J, Mackett K, Whitlock R, Worster A | 2018 | Clin Biochem | View The potential role of a turbidimetric heart-type fatty acid-binding protein assay to aid in the interpretation of persistently elevated, non-changing, cardiac troponin I concentrations | Researchers | Basic research |
Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Nagao M, Sengupta J, Diaz-Dussan D, Adam M, Wu M, Acker J, Ben R, Ishihara K, Zeng H, Miura Y, Narain R | 2018 | ACS Appl Bio Mater | View Synthesis of Highly Biocompatible and Temperature-Responsive Physical Gels for Cryopreservation and 3D Cell Culture | Researchers | Basic research |
A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Dyer C, Alquist CR, Cole-Sinclair M, Curnow E, Dunbar NM, Estcourt LJ, Kaufman R, Kutner JM, McCullough J, McQuilten Z, Potiphar L, Rioux-Masse B, Slichter S, Tinmouth A, Webert K, Yokoyama AP, Stanworth SJ | 2018 | Vox Sang | View A multicentred study to validate a consensus bleeding assessment tool developed by the biomedical excellence for safer transfusion collaborative for use in patients with haematological malignancy | Health care providers | Clinical research |
Questioning some recommendations in the umbilical cord blood guideline | Elmoazzen H, Petraszko T | 2018 | J Obstet Gynaecol Can | View Questioning some recommendations in the umbilical cord blood guideline | Health care providers | New or improved product or process |
ResearchUnit: A model for change: predicting the impact of system-wide improvements | Blake J | 2018 | Blood.ca website | View ResearchUnit: A model for change: predicting the impact of system-wide improvements | Other | New or improved product or process |
Screening of red blood cells for extracellular vesicle content as a product quality indicator | Acker JP, Almizraq RJ, Millar D, Maurer-Spurej E | 2018 | Transfusion | View Screening of red blood cells for extracellular vesicle content as a product quality indicator | Researchers | New or improved product or process |
Anti-M (French) | Clarke G, Cote J, Lane D | 2018 | Blood.ca website | View Anti-M (French) | Researchers | Basic research |
Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Langlois GP, Arnold DM, Potts J, Leber B, Dale DC, Mackey MC | 2018 | Clin Case Rep | View Cyclic thrombocytopenia with statistically significant neutrophil oscillations | Health care providers | Clinical research |
Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Qu M, Liu Q, Zhao H-G, Peng J, Ni H, Hou M, Jansen AJG | 2018 | Ann Hematol | View Low platelet count as risk factor for infections in patients with primary immune thrombocytopenia: a retrospective evaluation | Health care providers | Clinical research |
Changes in plasma unit distributions to hospitals over a 10-year period | Seheult JN, Shaz B, Bravo M, Croxon H, Devine D, Doncaster C, Field S, Flanagan P, Germain M, Gregoire Y, Kamel H, Karafin M, Kelting N, Lewis M, O'Brien C, Murphy MF, Rossmann S, Sayers M, Shinar E, Takanashi M, Titlestad K, Yazer MH | 2018 | Transfusion | View Changes in plasma unit distributions to hospitals over a 10-year period | Blood operators | Clinical research |
ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Branch D | 2018 | Blood.ca website | View ResearchUnit: Patient blood group impacts susceptibility to IVIg-associated hemolysis | Researchers | Basic research |
A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Del Fiol G MM, Iorio A, Cotoi C, Haynes RB | 2018 | J Med Internet Res | View A Deep Learning Method to Automatically Identify Reports of Scientifically Rigorous Clinical Research from the Biomedical Literature: Comparative Analytic Study | Researchers | Clinical research |
Circular of information for the use of human blood components: Platelets | Jenkins C | 2018 | Blood.ca website | View Circular of information for the use of human blood components: Platelets | Health care providers | Benchmarking and standard setting |
Aphérèse thérapeutique | Pavenski K | 2018 | Guide de la pratique transfusionnelle | View Aphérèse thérapeutique | Health care providers | Benchmarking and standard setting |
Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Shih AW, Liu A, Elsharawi R, Crowther MA, Cook RJ, Heddle NM | 2018 | Transfusion | View Systematic reviews of guidelines and studies for single versus multiple unit transfusion strategies | Researchers | Clinical research |
Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Wong PPC, Kariminia A, Jones D, Eaves CJ, Foley R, Ivison S, Couban S, Schultz KR | 2018 | Blood | View Plerixafor effectively mobilizes CD56bright NK cells in blood, providing an allograft predicted to protect against GVHD | Health care providers | Clinical research |